HOMA-IR - The Best Insulin Resistance Test

What Is HOMA-IR and Why Should You Care?

If you have been tracking your blood sugar and wondering why your numbers look "fine" even though you feel off, there is a good chance your standard lab work is missing something big. Dr. Eric Berg makes a strong case in this video that HOMA-IR (Homeostatic Model Assessment of Insulin Resistance) is the single best screening tool for catching insulin resistance early, often years before fasting glucose or A1C start looking abnormal. For anyone considering or currently using GLP-1 medications, understanding your baseline insulin resistance gives you a much clearer picture of what these drugs are actually treating in your body.

Here is the core idea: your body can keep blood sugar in a normal range for a surprisingly long time by pumping out more and more insulin. Standard glucose tests only look at the sugar side of that equation. HOMA-IR looks at both fasting glucose and fasting insulin together, which means it can spot the problem while your body is still compensating. Think of it like checking both the speedometer and the engine RPMs. Your speed might look fine, but if the engine is redlining to maintain it, something is wrong under the hood. This analogy is simple, but it captures the core limitation of glucose-only testing that affects millions of people who are told their labs look normal when they are anything but normal.

Berg walks through the formula (fasting glucose in mg/dL multiplied by fasting insulin in uIU/mL, divided by 405) and explains what different scores mean. A HOMA-IR under 1.0 is optimal. Between 1.0 and 1.9 suggests early insulin resistance. Above 2.0 is a red flag, and above 2.9 typically indicates significant insulin resistance. The math itself is simple enough to do on a phone calculator, but the insight it provides is genuinely powerful for early detection. Most people have never heard of this test, and Berg argues convincingly that it should be as routine as a cholesterol panel.

Why Standard Blood Tests Miss the Boat

One of the most useful parts of this video is Berg's explanation of why so many people get told they are "pre-diabetic" or "diabetic" when they thought everything was fine. The standard metabolic panel that most doctors order checks fasting glucose and sometimes A1C, but rarely includes fasting insulin. Without that insulin number, you are flying blind. It is like evaluating the health of a business by only looking at revenue without checking expenses. The revenue number might look acceptable even as the company is hemorrhaging money to maintain it.

Berg describes a common scenario: someone has a fasting glucose of 95 mg/dL, which falls within the normal range. Their doctor tells them everything looks good. But if you checked their fasting insulin and found it at 25 uIU/mL (well above optimal), their HOMA-IR would be 5.9, which is deep into insulin resistance territory. Their pancreas is working overtime to keep that glucose number looking acceptable, and nobody noticed because nobody ordered the right test. This happens in doctor's offices every single day, and the patient walks out with a false sense of security while their metabolic health continues to deteriorate silently.

This happens more often than you might think. Some estimates suggest that up to 88% of American adults have some degree of metabolic dysfunction, and many of them have normal-looking glucose numbers. The disconnect between how widespread insulin resistance is and how rarely it is tested for is one of the biggest blind spots in standard primary care. HOMA-IR catches the ones who are quietly heading toward trouble but would not show up on a standard screening. The test costs roughly $20-30 at most labs, making the cost-to-value ratio absurdly good for something that can detect metabolic problems a decade before they become diagnosable diseases.

The practical advice here is straightforward: ask your doctor to add fasting insulin to your next blood panel. It is an inexpensive test that most labs can run. If your doctor pushes back or says it is unnecessary, Berg suggests being persistent because the information gap between glucose-only testing and HOMA-IR testing is real and clinically meaningful. You can also order the test yourself through direct-to-consumer lab services, which often charge less than what you would pay through insurance.

What to Do With Your HOMA-IR Score

Berg does more than explain the test. He spends a good chunk of the video talking about what to do if your number comes back high. His primary recommendations center on reducing insulin demand through dietary changes, specifically lowering carbohydrate intake, extending the time between meals, and incorporating more healthy fats and proteins that do not spike insulin as aggressively. These are not radical or extreme approaches. They are adjustments that reduce the workload on your pancreas and give your cells a chance to become more sensitive to insulin again.

He also touches on the role of exercise, sleep, and stress management in improving insulin sensitivity. Resistance training gets a specific mention because muscle tissue acts as a glucose sink, pulling sugar out of the bloodstream without requiring as much insulin. If you are someone who has been doing only cardio and wondering why your metabolic markers are not improving, this might be worth paying attention to. Muscle mass is genuinely one of the most protective factors against insulin resistance, and building it while you are on a GLP-1 medication is especially smart because these drugs can promote muscle loss alongside fat loss if you are not actively working to preserve it.

The video also briefly mentions that certain nutrients like chromium, berberine, and apple cider vinegar have some evidence supporting their role in improving insulin sensitivity. Berg does not oversell these, but he presents them as potential additions to a broader lifestyle strategy. The evidence for berberine in particular is reasonably strong, with some studies showing effects on blood sugar and insulin that are comparable to metformin, though the quality of studies varies and it should not be treated as a substitute for medical treatment without your doctor's involvement.

Questions to Bring to Your Doctor

If this video motivates you to look into your own HOMA-IR, here are some useful questions to have ready for your next appointment. First, ask specifically for a fasting insulin test alongside your usual glucose panel. Second, ask your doctor what they consider an optimal fasting insulin level, more than the lab reference range (which can be quite wide and often includes values that many metabolic experts would consider too high). Third, if your HOMA-IR comes back elevated, ask about a structured approach to improving it, including whether dietary changes alone might be enough or whether medication should be part of the plan. Fourth, ask about retesting intervals so you can track whether your interventions are actually moving the needle. And finally, if you are already on a GLP-1 medication, ask how your HOMA-IR should be tracked during and after treatment, since these drugs directly affect the insulin dynamics that HOMA-IR measures.

What This Video Gets Right and What It Misses

Berg does an excellent job making a complicated concept accessible. The car analogy works well, the formula explanation is clear, and the case for why HOMA-IR should be standard screening is convincing. He is right that this test is underused in routine medical care, and he is right that catching insulin resistance early gives you far more options for reversing it. The presentation is efficient and does not waste time on filler, which respects the viewer's time while still covering the material thoroughly.

Where the video falls a bit short is in acknowledging the limitations of HOMA-IR. It is a fasting-state snapshot, which means it does not capture how your body responds to actual meals. An oral glucose tolerance test with insulin measurements at multiple time points gives a more complete picture, though it is also more expensive and time-consuming. Berg also does not spend much time discussing how HOMA-IR interacts with medications that affect insulin levels, such as metformin or GLP-1 receptor agonists. If you are already on one of these medications, your HOMA-IR might look artificially better without your underlying insulin resistance actually being resolved. This is an important nuance for the large number of viewers who are likely watching this video specifically because they are on or considering GLP-1 therapy.

The dietary recommendations are solid but somewhat one-size-fits-all. Low-carb approaches work well for many people with insulin resistance, but they are not the only effective strategy. Some individuals do very well with moderate carb intake combined with high fiber and regular exercise. Mediterranean-style eating patterns have strong evidence for improving insulin sensitivity without requiring strict carbohydrate restriction. The video could benefit from a broader perspective on dietary approaches that improve insulin sensitivity, giving viewers more options to find what is sustainable for their individual circumstances.

Who Should Watch This

This video is most useful for anyone who suspects they might have metabolic issues but keeps getting told their labs look normal. If you have a family history of type 2 diabetes, carry extra weight around your midsection, feel tired after meals, or have been diagnosed with PCOS, fatty liver, or high triglycerides, HOMA-IR testing could give you information that standard panels miss. It is also a good watch for anyone currently on a GLP-1 medication who wants to understand the underlying insulin dynamics that these drugs are affecting. Even if you are already being treated, knowing your HOMA-IR gives you a baseline for measuring whether the root cause is actually improving or whether the medication is just managing symptoms. That distinction matters a lot for making informed decisions about how long to continue treatment and what lifestyle changes should accompany medication.